GENE REWRITING

Serial Number 88921526
602

Registration Progress

Application Filed
May 18, 2020
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: GENE REWRITING
Previous Owner: Tessera Therapeutics, Inc.
Classes: 042

Trademark Image

GENE REWRITING

Basic Information

Serial Number
88921526
Filing Date
May 18, 2020
Abandonment Date
July 25, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Aug 21, 2023
Classes
042

Rights Holder

Tessera Therapeutics, Inc.

03
Address
101 South Street, Suite 300
Somerville, MA 02143

Ownership History

Tessera Therapeutics, Inc.

Original Applicant
03
Somerville, MA

Legal Representation

Attorney
Christina M. Licursi

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

44 events
Date Code Type Description Documents
Aug 21, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Aug 21, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Aug 21, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Apr 21, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Apr 21, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Apr 6, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 6, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 6, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 24, 2023 GNS1 O NOTIFICATION OF SUBSEQUENT FINAL EMAILED Loading...
Jan 24, 2023 GNSF O SUBSEQUENT FINAL EMAILED Loading...
Jan 24, 2023 CFRC R SUBSEQUENT FINAL REFUSAL WRITTEN Loading...
Dec 13, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 13, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 13, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 13, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 13, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jun 13, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 19, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 18, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 18, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 19, 2021 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Oct 16, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 16, 2021 GNRT O NON-FINAL ACTION E-MAILED Loading...
Oct 16, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 16, 2021 IUAA P USE AMENDMENT ACCEPTED Loading...
Sep 15, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 14, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 14, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Sep 15, 2021 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Sep 15, 2021 IUAF S USE AMENDMENT FILED Loading...
Sep 14, 2021 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Mar 15, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 15, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
Mar 15, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
Feb 19, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 18, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 18, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 19, 2020 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Aug 19, 2020 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Aug 19, 2020 EPEN O COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY Loading...
Aug 19, 2020 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
Aug 16, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 3, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 21, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Development of new technology for others for enabling the engineering and modification of DNA, namely, developing molecular and cellular biology reagents, techniques, and assays for the modification of cells and DNA
First Use Anywhere: Sep 7, 2021
First Use in Commerce: Sep 7, 2021

Classification

International Classes
042